A carregar...
Epigenetic adaptation to therapy in glioblastoma: popping the hood on therapeutic resistance
Glioblastoma (GBM), the most common and aggressive primary brain tumor in adults, remains one of most intractable diseases. Median survival remains at only 15 months, despite aggressive combination therapy involving surgical resection, radiation, and alkylating chemotherapy. While initially responsi...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168893/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy130.079 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|